China Diagnostic Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The China Diagnostic Imaging Market Report is Segmented by Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Other Applications), And  End User (Hospitals, Diagnostic Centers, and Other End Users). The Report Offers the Market Size and Forecasts in Value (USD) for the Above Segments.

China Diagnostic Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

China Diagnostic Imaging Market Size

China Diagnostic Imaging Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 3.37 Billion
Market Size (2030) USD 4.51 Billion
CAGR (2025 - 2030) 6.00 %
Market Concentration High

Major Players

China Diagnostic Imaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of China Diagnostic Imaging Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

China Diagnostic Imaging Market Analysis

The China Diagnostic Imaging Market size is estimated at USD 3.37 billion in 2025, and is expected to reach USD 4.51 billion by 2030, at a CAGR of 6% during the forecast period (2025-2030).

The market is expected to show healthy growth owing to the growing prevalence of chronic diseases, the growing geriatric population, and the increased adoption of advanced technologies in medical imaging.

China is experiencing a significant increase in chronic diseases such as cardiovascular diseases, diabetes, cancer, and respiratory disorders. This rise is driven by aging populations, lifestyle changes, and environmental factors. For instance, as per an article published in Frontier in Public Health in October 2023, in China, approximately 6.0% of individuals aged 60 and older are estimated to have Alzheimer's disease. Projections indicate that by 2030, the aging demographic could push the number of cases to over 20 million. Additionally, according to the International Diabetes Federation, 164.6 million people are projected to be diagnosed with diabetes, with this number expected to rise to 174.4 million by 2045. Thus, as chronic diseases become more prevalent, there is a heightened demand for early and accurate diagnosis. This drives the need for advanced imaging technologies and will likely support the market expansion during the forecast period.

Also, the government support and strategic initiatives taken in the country that bolster the adoption of diagnostic imaging are likely to spur market growth during the forecast period. For instance, in March 2024, the Chinese government initiated the "One Thousand Counties Project," targeting enhancing healthcare infrastructure in rural regions. The project enhances hospital capabilities by integrating advanced imaging technologies such as CT and MRI scanners. This move aligns with the government's commitment to augment healthcare access for its aging populace. Thus, such initiatives are expected to increase demand for diagnostics imaging in the country, driving market growth.

The introduction of innovative imaging technologies, such as MRI, CT, PET, and ultrasound machines, is transforming the diagnostics landscape in China. Advances in imaging resolution, speed, and functionality make these tools more practical and are expected to propel the market's growth. For instance, in February 2023, Mindray, a China-based developer and provider of advanced medical devices and solutions, launched its first wireless handheld ultrasound system, the TE Air. Additionally, in February 2023, GE Healthcare formed a long-term joint venture with a subsidiary of a Chinese state-owned drugmaker to provide non-premium CT and general imaging ultrasound solutions. Thus, such launches and collaboration are expected to increase the adoption of imaging equipment that can offer a broader range of services, which is anticipated to bolster the market growth.

Thus, the high burden of chronic diseases, supportive government initiatives, and increasing product launches and collaboration initiatives by the industry players are expected to contribute to market growth during the forecast period. However, the high cost associated with devices and the side effects of diagnostic imaging may hamper the development of the market during the forecast period.

China Diagnostic Imaging Industry Overview

The Chinese diagnostic imaging market is moderately consolidated and competitive. The market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are dominating the market. Some companies dominating the market are Canon Medical Systems Corporation, Carestream Health Inc., Fujifilm Holdings, GE Healthcare (GE Company), and Hologic Corporation.

China Diagnostic Imaging Market Leaders

  1. Fujifilm Holding

  2. GE Healthcare (GE Company)

  3. Hologic Corporation

  4. Siemens Healthcare

  5. Canon Medical Systems Corporation

  6. *Disclaimer: Major Players sorted in no particular order
China Diagnostic Imaging Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

China Diagnostic Imaging Market News

  • May 2024: United Imaging, a global frontrunner in the production of cutting-edge medical imaging and radiotherapy equipment, showcased its state-of-the-art MRI technology, highlighting significant advancements across multiple dimensions.
  • October 2023: Sinotau Pharmaceutical Group and Blue Earth Diagnostics Ltd entered a collaboration to introduce a groundbreaking PSMA-targeted PET imaging agent to the Chinese market.

China Diagnostic Imaging Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Prevalence of Chronic Diseases
    • 4.2.2 Growing Geriatric Population
    • 4.2.3 Increased Adoption of Advanced Technologies in Medical Imaging
  • 4.3 Market Restraints
    • 4.3.1 High Costs Associated With the Devices
    • 4.3.2 Side Effects of Diagnostic Imaging Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Modality
    • 5.1.1 MRI
    • 5.1.1.1 Low and Mid-field MRI Systems (less than 1.5 T)
    • 5.1.1.2 High field MRI Systems (1.5-3 T)
    • 5.1.1.3 Very High and Ultra High Field MRI Systems (3T and More)
    • 5.1.2 Computed Tomography
    • 5.1.2.1 Low End Scanners (~16-Slice)
    • 5.1.2.2 Mid Range Scanners (~64-Slice)
    • 5.1.2.3 High End Scanners (128-Slice and More)
    • 5.1.3 Ultrasound
    • 5.1.3.1 2D Ultrasound
    • 5.1.3.2 3D Ultrasound
    • 5.1.3.3 Other Ultrasound
    • 5.1.4 X-ray
    • 5.1.4.1 Analog Systems
    • 5.1.4.2 Digital Systems
    • 5.1.5 Nuclear Imaging
    • 5.1.5.1 Positron Emission Tomography (PET)
    • 5.1.5.2 Single Photon Emission Computed Tomography (SPECT)
    • 5.1.6 Fluoroscopy
    • 5.1.7 Mammography
  • 5.2 By Application
    • 5.2.1 Cardiology
    • 5.2.2 Oncology
    • 5.2.3 Neurology
    • 5.2.4 Orthopedics
    • 5.2.5 Gastroenterology
    • 5.2.6 Gynecology
    • 5.2.7 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems Corporation
    • 6.1.2 Carestream Health Inc.
    • 6.1.3 Fujifilm Holding
    • 6.1.4 GE Healthcare (GE Company)
    • 6.1.5 Neusoft Medical Systems Co. Ltd
    • 6.1.6 Hologic Corporation
    • 6.1.7 Philips Healthcare
    • 6.1.8 Shimadzu Medical
    • 6.1.9 Siemens Healthcare
    • 6.1.10 Shenzhen Anke High-tech Co. Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

China Diagnostic Imaging Industry Segmentation

As per the scope of the report, diagnostic imaging captures images of the internal structure of the human body using electromagnetic radiation for an accurate diagnosis. There are various types of medical imaging, the most common ones being CT scanners, MRI systems, etc.

The Chinese diagnostic imaging market is segmented by modality, application, and end user. By modality, the market is segmented as MRI, computed tomography, ultrasound, X-ray, nuclear imaging, fluoroscopy, and mammography. By MRI, the market is further sub-segmented into low and mid-field MRI systems (less than 1.5 T), high-field MRI systems (1.5-3 T), and very high and ultra-high field MRI systems (3T and more). By computed tomography, the market is further sub-segmented as low-end scanners (~16-slice), mid-range scanners (~64-slice), and high-end scanners (128-slice and more). By ultrasound, the market is further sub-segmented into 2D ultrasound, 3D ultrasound, and other ultrasound. By X-ray, the market is sub-segmented into analog systems and digital systems. By nuclear imaging, the market is sub-segmented into positron emission tomography (PET) and single photon emission computed tomography (SPECT). By application, the market is segmented as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and other applications. By end user, the market is segmented as hospitals, diagnostic centers, and other end users. The report offers the market size and forecasts in value (USD) for the above segments.

By Modality MRI Low and Mid-field MRI Systems (less than 1.5 T)
High field MRI Systems (1.5-3 T)
Very High and Ultra High Field MRI Systems (3T and More)
Computed Tomography Low End Scanners (~16-Slice)
Mid Range Scanners (~64-Slice)
High End Scanners (128-Slice and More)
Ultrasound 2D Ultrasound
3D Ultrasound
Other Ultrasound
X-ray Analog Systems
Digital Systems
Nuclear Imaging Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Fluoroscopy
Mammography
By Application Cardiology
Oncology
Neurology
Orthopedics
Gastroenterology
Gynecology
Other Applications
By End User Hospitals
Diagnostic Centers
Other End Users
Need A Different Region or Segment?
Customize Now

China Diagnostic Imaging Market Research Faqs

How big is the China Diagnostic Imaging Market?

The China Diagnostic Imaging Market size is expected to reach USD 3.37 billion in 2025 and grow at a CAGR of 6% to reach USD 4.51 billion by 2030.

What is the current China Diagnostic Imaging Market size?

In 2025, the China Diagnostic Imaging Market size is expected to reach USD 3.37 billion.

Who are the key players in China Diagnostic Imaging Market?

Fujifilm Holding, GE Healthcare (GE Company), Hologic Corporation, Siemens Healthcare and Canon Medical Systems Corporation are the major companies operating in the China Diagnostic Imaging Market.

What years does this China Diagnostic Imaging Market cover, and what was the market size in 2024?

In 2024, the China Diagnostic Imaging Market size was estimated at USD 3.17 billion. The report covers the China Diagnostic Imaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Diagnostic Imaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

China Diagnostic Imaging Industry Report

Statistics for the 2025 China Diagnostic Imaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Diagnostic Imaging analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.